dc.contributor.author | Smith, TH | en_US |
dc.contributor.author | Blume, LC | en_US |
dc.contributor.author | Straiker, A | en_US |
dc.contributor.author | Cox, JO | en_US |
dc.contributor.author | David, BG | en_US |
dc.contributor.author | Mcvoy, JRS | en_US |
dc.contributor.author | Sayers, KW | en_US |
dc.contributor.author | Poklis, JL | en_US |
dc.contributor.author | Abdullah, RA | en_US |
dc.contributor.author | Egertova, M | en_US |
dc.contributor.author | Chen, C-K | en_US |
dc.contributor.author | Mackie, K | en_US |
dc.contributor.author | Elphick, MR | en_US |
dc.contributor.author | Howlett, AC | en_US |
dc.contributor.author | Selley, DE | en_US |
dc.date.accessioned | 2015-11-04T12:17:53Z | |
dc.date.issued | 2015-04 | en_US |
dc.identifier.issn | 0026-895X | en_US |
dc.identifier.other | 10.1124/mol.114.096495 | |
dc.identifier.uri | http://molpharm.aspetjournals.org/content/87/4/747.long | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/9311 | |
dc.description | This article has supplemental material available at molpharm.aspetjournals.org. | en_US |
dc.description.sponsorship | National Institutes of Health National Institute on Drug Abuse [R21-DA025321, R01-DA003690, R03-DA035424, F31-DA023747, F31-DA032215, R01-DA011322, K05-DA021696, and T32-DA007027], the National Institute on Neurologic Disorders and Stroke [T32-NS007288], the National Eye Institute [R21-EY021831], the Biotechnology and Biological Sciences Research Council [S19916], and the National Center for Advancing Translational Sciences [UL1-TR000058] in support of the A.D. Williams Fund of Virginia Commonwealth University. Mass spectrometry was supported in part with funding from the National Institute on Drug Abuse [P30-DA033934]. Rat microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported in part with funding from the National Institute on Neurologic Disorders and Stroke [P30-NS047463]. | en_US |
dc.format.extent | 747 - 765 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | MOLECULAR PHARMACOLOGY | en_US |
dc.rights | This is a pre-copyedited, author-produced version of an article accepted for publication in Molecular Pharmacology following peer review. The version of record is available http://molpharm.aspetjournals.org/content/87/4/747 | |
dc.title | Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation | en_US |
dc.type | Article | |
dc.rights.holder | Copyright © 2015 by the American Society for Pharmacology and Experimental Therapeutics | |
dc.identifier.doi | 10.1124/mol.114.096495 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352004100018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 4 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 87 | en_US |
qmul.funder | Neuropeptide function in a decentralised nervous system::Biotechnology and Biological Sciences Research Council | en_US |